Archive for June 4, 2021
June 4, 2021
Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tvmh) for the treatment of patients with plasminogen deficiency type 1, also referred to as…
June 4, 2021
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On June 1, the…
Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight…
Latest Posts
FDA Publishes Filing Checklists to Prevent Submission Delays
October 23, 2025
Tags
Animal & Veterinary
Award
Biologics
Coronavirus
Cosmetics
Dietary Supplements
Drugs
Follow @FDAmedia on Twitter
Follow @FDAMedia on X
Follow @US_FDA on Twitter
Follow @US_FDA on X
Follow FDA on Facebook
Food & Beverages
Infant Formula & Foods
Infectious Disease
Medical Devices
Office
Over-the-Counter Drugs
Press Announcements
Tobacco
Training
Vaccines

